Primidone Tablets, 50 mg recall — Amneal Pharmaceuticals, LLC (Class III)
Amneal Pharmaceuticals, LLC is recorded by the U.S. Food and Drug Administration (FDA) as recalling Primidone Tablets, 50 mg — a Class III recall, initiated 2026-06-03 and posted to the FDA enforcement report on 2026-06-17, under recall number D-0585-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.”. From the product description, the form is tablets, the strength given is 50 mg, the package is described as 100 Tablets and it is marked Rx only. 1 National Drug Code number is printed in the record: 53746-544-01. Distribution is recorded as “Nationwide within the USA” — Nationwide (US), with the recalling firm on record in NJ, United States. It is the only recall number the FDA has filed under event ID 99146. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.
Regulatory snapshot
| Recall number | D-0585-2026 |
|---|---|
| FDA event ID | 99146 |
| Classification | Class III (least serious regulatory tier) |
| Status | Ongoing |
| Recalling firm | Amneal Pharmaceuticals, LLC |
| Recall initiated | 2026-06-03 |
| Reported by FDA | 2026-06-17 |
| Report lag | 14 days from initiation to report |
| Distribution | Nationwide within the USA. — Nationwide (US) |
| Firm location on record | NJ, United States |
| Product description (source) | Primidone Tablets, USP, 50 mg, 100 Tablets per Bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA. Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC: 53746-544-01 |
Reason reported by FDA
Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.
22 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.
Product identifiers in this record
7 identifying values matched by exact pattern in the 34-word product description above; each is a literal substring of it.
| Product named | Primidone Tablets |
|---|---|
| Form | Tablets |
| Strength | 50 mg |
| Package | 100 Tablets |
| NDC | 53746-544-01 |
| Marketing category | Rx only |
| Manufactured by | Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit |
| Distributed by | Amneal Pharmaceuticals LLC, Bridgewater |
Other indexed recalls of primidone
6 indexed records name primidone as the recalled substance. Matching is on the product-name prefix of the FDA's own text, so other strengths and packages are included.
| Recall record | Recall number | Recalling firm | Strength / form | Reported |
|---|---|---|---|---|
| Primidone Tablets USP, 250mg | D-0533-2026 | Lannett Company Inc. | 250mg · Tablets | 2026-05-27 |
| Primidone Tablets, 50 mg | D-0534-2026 | Golden State Medical Supply Inc. | 50 mg · Tablets | 2026-05-27 |
| Primidone Tablets, 250 mg | D-0535-2026 | Golden State Medical Supply Inc. | 250 mg · Tablets | 2026-05-27 |
| Primidone Tablets, 250 mg | D-0536-2026 | Amerisource Health Services LLC | 250 mg · Tablets | 2026-05-27 |
| Primidone Tablets, 50 mg | D-0537-2026 | Amerisource Health Services LLC | 50 mg · Tablets | 2026-05-27 |
Reported in the same month (2026-06)
74 enforcement reports carry a report date in 2026-06; these 5 are the Class III ones nearest this record.
| Recall record | Recall number | Recalling firm | FDA tier | Reported |
|---|---|---|---|---|
| Epinephrine Injection, 1mg/mL | D-0581-2026 | Fresenius Kabi Usa, LLC | Class III | 2026-06-17 |
| Lidocaine HCl Injection, 2% | D-0552-2026 | Eugia US LLC | Class III | 2026-06-10 |
| Focalin XR (dexmethylphenidate HCl) 5 mg | D-0608-2026 | Sandoz Inc | Class III | 2026-06-24 |
| Nicotine Transdermal System Patch, 14 mg | D-0550-2026 | Aveva Drug Delivery Systems, Inc. | Class III | 2026-06-03 |
| PRED MILD, 0.12% | D-0551-2026 | Abbvie Inc. | Class III | 2026-06-03 |
Nearest Class III recalls by date
25 of 250 indexed records share the Class III tier; the 6 nearest to 2026-06-17 by report date are listed here.
| Recall record | Recall number | Recalling firm | Strength / form | Reported |
|---|---|---|---|---|
| hydrOXYzine Hydrochloride Oral Solution, 10 mg/5 mL | D-0619-2026 | Ani Pharmaceuticals, Inc. | 10 mg/5 mL · Oral Solution | 2026-07-01 |
| Busulfan Injection, 60 mg | D-0539-2026 | Sagent Pharmaceuticals | 60 mg · Injection | 2026-05-27 |
| Fexofenadine Hydrochloride Tablets, 180 mg | D-0654-2026 | Sun Pharmaceutical Industries Inc | 180 mg · Tablets | 2026-07-08 |
| busPIRone Hydrochloride Tablets, 5 mg | D-0511-2026 | Unichem Pharmaceuticals Usa Inc. | 5 mg · Tablets | 2026-05-13 |
| Levocarnitine Injection, 1 g/5 mL | D-0494-2026 | American Regent, Inc. | 1 g/5 mL · Injection | 2026-05-06 |
| Lidocaine Wound Gel, 0.13% | D-0509-2026 | Water-jel Technologies, LLC | 0.13% · Gel | 2026-05-06 |
Reading this record
Class III is the FDA's own severity tier for the recall action — 25 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. Match a package against 53746-544-01 at the FDA source to confirm it is covered.
Namespace context: the Class III index (25 records) and the recall hub (250 records, 118 FDA events); Amneal Pharmaceuticals, LLC (1 indexed records) aggregates this firm across datasets.
Coverage and limits of this record
This page reflects the openFDA enforcement report for D-0585-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.
Source & provenance
- Official source
- https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0585-2026%22
- Source dataset
- openFDA Drug Enforcement API
- Publication date
- 2026-06-17
- Ingested
- 2026-08-22
- Record hash
0f2009080f666a36
Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.